|Articles|September 1, 1999

September 1999
Volume 5
Issue 9

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

Author(s)Edmund R. Becker, PhD, Douglas C. Morris, MD, Steven D. Culler, PhD

Download PDF: The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

Articles in this issue

over 26 years ago

Article

Was the Decreasing Trend in Hospital Mortality from Heart Failure Attributable to Improved Hospital Care? The Oregon Experience, 1991-1995

over 26 years ago

Article

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

over 26 years ago

Article

Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants

over 26 years ago

Article

Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?

over 26 years ago

Article

Patient Factors Related to the Odds of Receiving Prevention Services in Veterans Health Administration Medical Centers

over 26 years ago

Article

Innovative Healthcare for Chronically Ill Older Persons: Results of a National Survey

over 26 years ago

Article

Office-Based Surgery and Cost Avoidance in an Obstetrics and Gynecology Residency Program

over 26 years ago

Article

Drug Therapy of Allergic Rhinitis

over 26 years ago

Article

Rethinking Formulary Strategy: Management and Measurement Considerations

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD